Company / Operating Income
ALX ONCOLOGY HOLDINGS INC Operating Income History
FY2020-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$127.4M
FY2022
5-year range
-$127.4M / -$13.7M
FY2020-FY2022
Trend
-564.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income changed -564% YoY in FY2022, a notable deviation from the 2-year average annual change of -302%.
Based on SEC 10-K filings.
-$127M in FY2022.
Declined from -$14M to -$127M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income decreased 564.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$127.4M | -564.3% |
| FY2021 | -$19.2M | -40.2% |
| FY2020 | -$13.7M | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026